{"product_id":"synthetic-biology-market-by-tools-oligonucleotides-enzymes-synthetic-cells-technology-genome-engineering-bioinformatics-applications-tissue-regeneration-biofuel-food-agriculture-consumer-care-environmental-global-forecast-to-2027","title":"Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027","description":"\u003cp\u003eSynthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027\u003c\/p\u003e\n\n\u003cp\u003eThe global synthetic biology market size is projected to reach USD 35.7 billion by 2027 from USD 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period. Factors such as increasing investment in synthetic biology research, declining cost of DNA sequencing, increasing adoption of synthetic biology across various industries are driving the market growth at faster pace.\u003c\/p\u003e\n\n\u003cp\u003e“The oligonucleotides and synthetic DNA segment is likely to grow at highest CAGR during the forecast period of 2022-2027.”\u003c\/p\u003e\n\n\u003cp\u003eOn the basis of tools, the synthetic biology market is segmented into oligonucleotides \u0026amp; synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides and synthetic DNA segment is projected to grow at highest CAGR during the forecast period. The growth is attributed to increased demand for synthetic DNA, synthetic RNA, and synthetic genes across various industries. Furthermore, launch of novel products in the market is further likely to have positive impact on the segmental growth.\u003c\/p\u003e \n\n\u003cp\u003e“The gene synthesis segment held dominant share in 2021.”\u003c\/p\u003e\n\n\u003cp\u003eBased on technology, the market is segmented into gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology. The genome engineering segment is expected to grow at faster pace during the the forecast period due to factors such as the use of these techniques in therapeutics development, advancement in CRISPR technologies is increasing adoption.\u003c\/p\u003e\n\n\u003cp\u003e“in 2021, medical applications segment held dominant share.”\u003c\/p\u003e\n\n\u003cp\u003eBased on application, the synthetic biology market is segmented into medical applications, industrial applications, food \u0026amp; agriculture, and environmental applications. The medical applications segment held domiant share in synthetic biology market . Adoption of synthetic biology in research and drug discovery \u0026amp; development is one of the major factor anticipated to project the market growth.\u003c\/p\u003e \n\n\u003cp\u003e“Asia Pacific region is likely to grow at faster pace.”\u003c\/p\u003e\n\n\u003cp\u003eThe synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East \u0026amp; Africa. In 2021, North America accounted for the dominant share in synthetic biology market. The dominance of the region is attributable to various factors such as presence of dominant and key market players in the region coupled augmented use of synthetic biology in various application. Asia Pacific region is likely to grow at faster pace owing to various factors such as rise in demand for synthetic cells across the region, increased research and development funding and emergence of new market players in the synthetic biology market.\u003c\/p\u003e \n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 60%, and Demand Side - 40%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation (Supply Side): Managers - 45%, CXOs \u0026amp; Directors - 25%, Executives- 15%, Other -15.0%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%\u003c\/p\u003e\n\n\u003cp\u003eLists of Companies Profiled in the Report:\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific (US)\u003c\/p\u003e\n\n\u003cp\u003eMerck KGaA (Germany)\u003c\/p\u003e\n\n\u003cp\u003eAgilent Technologies (US)\u003c\/p\u003e\n\n\u003cp\u003eNovozymes (Denmark)\u003c\/p\u003e\n\n\u003cp\u003eGinkgo Bioworks (US)\u003c\/p\u003e\n\n\u003cp\u003eAmyris (US)\u003c\/p\u003e\n\n\u003cp\u003ePrecigen (US)\u003c\/p\u003e\n\n\u003cp\u003eGenScript Biotech Corporation (China)\u003c\/p\u003e\n\n\u003cp\u003eTwist Bioscience (US)\u003c\/p\u003e\n\n\u003cp\u003eSynthetic Genomics (US)\u003c\/p\u003e\n\n\u003cp\u003eCodexis (US)\u003c\/p\u003e\n\n\u003cp\u003eSynthego (US)\u003c\/p\u003e\n\n\u003cp\u003eCreative Enzymes (US)\u003c\/p\u003e\n\n\u003cp\u003eEurofins Scientific (Luxembourg)\u003c\/p\u003e\n\n\u003cp\u003eCyrus Biotechnology (US)\u003c\/p\u003e\n\n\u003cp\u003eATUM (US)\u003c\/p\u003e\n\n\u003cp\u003eTeselaGen (US)\u003c\/p\u003e\n\n\u003cp\u003eArzeda (US)\u003c\/p\u003e\n\n\u003cp\u003eIntegrated DNA Technologies (US)\u003c\/p\u003e\n\n\u003cp\u003eNew England Biolabs (US)\u003c\/p\u003e\n\n\u003cp\u003eElevate Bio (US)\u003c\/p\u003e\n\n\u003cp\u003eZENFOLD (Iosynth) (India)\u003c\/p\u003e\n\n\u003cp\u003eSynbio Technologies (US)\u003c\/p\u003e\n\n\u003cp\u003eInscripta, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eCRISPR Therapeutics (Switzerland).\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the synthetic biology market. It aims at estimating the size and future growth potential of the market across different segments, such as tool, technology, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall synthetic biology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 441 Pages \/ MCW16227393","offer_id":47645954933042,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/synthetic-biology-market-by-tools-oligonucleotides-enzymes-synthetic-cells-technology-genome-engineering-bioinformatics-applications-tissue-regeneration-biofuel-food-agriculture-consumer-care-environmental-global-forecast-to-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}